Liquidia (LQDA) EBT Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Liquidia | 6.39 Bn | 6.11 Bn | 160.92 Mn | 51,810.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51,810.00 |
| Mar 31, 2026 | 127,245.00 |
| Dec 31, 2025 | 133,601.00 |
| Sep 30, 2025 | 141,499.00 |
| Jun 30, 2025 | 136,917.00 |
| Mar 31, 2025 | 287,396.00 |
| Dec 31, 2024 | -71,437.00 |
| Sep 30, 2024 | -84,302.00 |
| Jun 30, 2024 | -144,245.00 |
| Mar 31, 2024 | -341,364.00 |
| Dec 31, 2023 | -51,012.00 |
| Sep 30, 2023 | -23,566.00 |
| Jun 30, 2023 | -74,171.00 |
| Mar 31, 2023 | -23,688.00 |
| Dec 31, 2022 | 26,115.00 |
| Sep 30, 2022 | -17,996.00 |
| Jun 30, 2022 | -13,044.00 |
| Mar 31, 2022 | 7,359.00 |
| Dec 31, 2021 | 181,307.00 |